Milestone Pharmaceuticals is trading 10.69% higher at $0.87 in pre-market, alongside healthcare’s 1.32% gain; the precise driver remains unconfirmed. - No confirmed company-specific announcement was found; the latest located press release was dated October 19. - The previously disclosed Nasdaq minimum-bid notice does not indicate a new overnight catalyst. - The move follows three consecutive higher closes, including a 4.25% gain on October 29, while broader market indicators are down.